6500 Stock Chart & Stats
€1.57
€0.00(0.00%)
At close: 4:00 PM EST
€1.57
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€1.57 - €1.57
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€195.32M
Enterprise Value€13.75
Total Cash (Recent Filing)€78.59K
Total Debt (Recent Filing)€1.80M
Price to Earnings (P/E)7.8
Beta-2.30
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding12,384,142
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-1.51
Price to Book (P/B)5.03
Price to Sales (P/S)5.30
P/FCF Ratio-135.35
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthA 52% revenue growth rate indicates strong demand for OpGen's diagnostic products, suggesting robust market positioning and potential for sustained growth.
Leadership ChangesThe appointment of experienced leaders in key roles can enhance strategic execution and operational efficiency, supporting long-term business objectives.
Product DemandAddressing antimicrobial resistance positions OpGen as a critical player in healthcare, driving sustained demand for its diagnostic solutions.
Bears Say
Financial SustainabilityReliance on external funding and high leverage can threaten financial stability, limiting the company's ability to invest in growth and innovation.
Cash Flow ChallengesPersistent negative cash flow reflects operational inefficiencies and may constrain the company's ability to fund operations and strategic initiatives.
Profitability IssuesOngoing unprofitability and negative margins highlight cost management issues, impacting long-term viability and competitive positioning.
CapForce News
6500 FAQ
What was CapForce’s price range in the past 12 months?
CapForce lowest stock price was €1.57 and its highest was €1.57 in the past 12 months.
What is CapForce’s market cap?
CapForce’s market cap is €195.32M.
When is CapForce’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were CapForce’s earnings last quarter?
Currently, no data Available
Is CapForce overvalued?
According to Wall Street analysts CapForce’s price is currently Overvalued.
Does CapForce pay dividends?
CapForce does not currently pay dividends.
What is CapForce’s EPS estimate?
CapForce’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CapForce have?
CapForce has 12,384,142 shares outstanding.
What happened to CapForce’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of CapForce?
Currently, no hedge funds are holding shares in DE:6500
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
CapForce
CapForce Inc. is a precision medicine company dedicated to developing and commercializing sophisticated molecular microbiology solutions. Its mission is to address life-threatening infectious diseases for patients in the United States and across international markets. The company's diverse product range includes Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel diagnostic tests, and SARS CoV-2 testing kits. Beyond its product line, CapForce extends its offerings to include laboratory services, collaboration services (such as funded software arrangements), and licensing agreements. Additionally, the company provides listing sponsorship and consultancy services. Formerly known as OpGen, Inc., the entity officially changed its name to CapForce Inc. in February 2026. CapForce Inc. was established in 2001 and maintains its headquarters in Clarksburg, Maryland.